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ABSTRACT
Previo us studies have revealed inconsistent results in exami ning the assoc iation of
MTHFR c.677C>T, c.1298A>C variants and 9p21 locus with ischemic stroke. This thesis
includes two case control studies by enrolling 1,429 ischemic stroke patients and 1,197
control individuals from the Chinese Han population. One study validates the assoc iation
between the candidate 9p2 1 locus and ischemic stroke both at the SNP and Haplotype
levels by genotyping four common variants encompassing a 44kb candidate risk region
on 9p2 1. Moreover, the haplotype analysis reduces the candidate risk region on 9p2 1
locus to 28 kb. The other study indicates that the MTHFR locus is assoc iated with
ischemic stroke in the Chinese Han population. The MTHFR c. 677C>T variant is a risk
factor, and its effect could be modified by genetic or environmental factors which vary
among differe nt ethnic populations. The MTHFR c. 1298A>C variant is more likely to
play the role of a genetic marker than a causative variant in assoc iation with ischemic
stroke. Combined analysis suggests the 9p21 locus and lvrrHFR risk alleles confer an
additive co-effec t for increased risk in ischemic stroke.
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Chapter 1
Stroke Introduction
1.1Stroke Definition and Clinical Features
Stroke, according to the World Health Organization (WHO), is rapidly developed focal or
global neurologica l deficits, persisting more than 24 hours or interrupted by intervention
or death within 24 hours, with a presumed vascular cause (WHO 1990). The clinical
symptoms of stroke vary depending on lesion size and location in the brain . The comm on
symptoms include hemiplegia, hemianesthesia, aphasia, vision field defects, dysarthria,
headache, conscious impairments, dysphonia and spatial neglects (Adams and Victoria
Principles of Neurology, s" edition, 2005).
Advances in neuroim aging technique s have helped in facilitating the diagnosis of stroke.
X-ray computed tomography (CT) scans can differentiate hemorrhagic from ischemic
stroke immediately afte r onset. Magnetic resonance imaging (MRI) perfusion weighted
imaging (PWI) and diffusion weighted imaging (OWl) mismatch scans can identi fy the
penum bra area where the affected brain tissue can be treated by thromb olysis in cases of
early ischemic stroke. MRI scans can identify the lesion location and size in the brain.
Magnetic resonance angiog raphy (MRA) scans or computed tomography angiography
(CTA) scans can reveal the morphological changes in cerebral vasculature (Warach et al.
1995; Baird et al. 1998; Peter et al. 2003).
1.2 Stroke Subtypes
Based on current neuroim aging examinations, the etiology of stroke is categor ized into
four subtypes: ischemic, intracranial hemorrhagic, subarachnoid hemorrhagic and
undetermined . Ischemic stroke results from the occlusion of cerebral arteries by thrombi
or emboli generated in the cardiovascular system, mainly due to atherosclerosis and atrial
fibrillation. Intracranial hemorrhage refers to situations in which blood leaks from
cerebral arteries into brain tissue. Subarachnoid hemorrhage is caused by rupture of an
aneurysm in the primary branches from the circle of Willis, and blood bursts into the
subarachnoid space. The undetermined type of stroke occurs when a neuroimaging
examination is unavailable (Adams and Victoria Principle of Neurology, s" edition,
2005).
The frequencies of stroke subtypes have been investigated worldwide. Ischemic stroke is
the leading subtype according to most studies. Feigin et al. (2003) pooled ten population-
based studies across European, Australian and Caribbean areas. Ischemic stroke was the
most frequent in these studies, whieh constituted 67.3% - 80.5% of all stroke events.
Intracranial hemorrhage, subarachnoid hemorrhage and unknown types accounted for
6.5% - 19.6%, 0.8% - 7.0%, and 2.0% - 14.5%, respectively. A similar frequency was
also observed in the Chinese population. A large comprehensive study was conducted by
the China Multicenter Collaborative Study of Cardiovascular Epidemiology (Zhang et al.
2003). A total of 16,031 first-time stroke patients (~25 years old) were registered in 17
communities from 1991 to 2000. A comparison of the frequency distribution of stroke
subtypes in 1991 and 2000 are shown in Figure 1.1. The ischemic stroke rate increased
from the second (30.2%) in 1991 to the most common subtype (6 1.9%) in 2000.
Intracranial hemorrhage accounted for 28.5% of cases in 2000, which was much higher
than 16.8%, as recorded in 1991. The reason for this difference lies in the
implementation of neuroimaging techniques during the study period. In 2000, 91.4% of
patients received CT scans, compared to that of 49.4% in 1991.
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Figure 1.1 Comparison of the frequency of four subtypes of stroke in China durin g 1991
and 2000 (Adapted from Zhang et al. 2003) (IS: ischemic stroke, ICH: intracranial
hemorrhage, SAH: subarachnoid hemorrhage; UNO: undetermined)
1.3 Stroke Epidemiology
Prevalence: 9.0 million individuals are estimate d to suffer from stroke wor ldwide each
year , whi le approximately 1.5 to 2.0 million patients reside in China (Liu et al. 2007;
Meretoja 20 11). Stroke occurs in individuals from all age groups, with an increasing trend
after 30 years old. About 95% of stroke events affect individuals older than 45 years old,
and two thirds occur in individuals over 65 years old (Senelick et al. 1994). In China, the
mean onset for stroke is 63.9±8.4 years old for males and 64.9±7.0 years old for femal es
(Zhao et al. 2008).
Incidence: The incidence of stroke showed an increasing trend in the past three decades in
China. Zhao et al. (2008) observed 14,585 consecutive acute stroke events in Beij ing
from 1984 to 2004, confined to patients aged 25 through 74 years old. The annual
incidence increased by 6.7% and 8.7% for total and ischemic stroke events, respectively.
The increasing incidence was assoc iated with rapid development during the three
decades, which has led to a grow ing number of senior individuals with prolonged life
expectancy. Also, a shift to a westernized lifestyle in Chinese socie ty, especially in cities,
may contribute to increased atherosc lerotic risk factors. This study also recorded the
increas ing intake of fat and cholesterol during the study period. Fat intake increased from
88.1 g1dto 97.4 g/d, while cholesterol intake increased from 334.5 g1d to 488.4 g/d from
1983 to 2002. The prevalence of type 2 diabetes mellitus and obesity also increased by
97% and 85% in rural areas, respectively (Liu et al. 2007; Zhao et al. 2008).
Mortality: Stroke is the second most common cause of adult death worldwide . Stroke-
related deaths showed an upward trend during the two decades, increasing from 4.4
million in 1990 to 5.7 million in 2004, which approximately constituted 9.7% of total
deaths worldwide (Murray et al. 1997; Bonita et al. 2004; Geneva : World Health
Organization. 2000, 2004; Donnan et al. 2008; Mathers et al. 2009). The World Health
Organiza tion (2000) estimates that stroke and coronary artery disease will rank as the top
cause for lost healthy life-years by the year 2020. According to a report from the World
Health Organization, 85% of stroke-related deaths occur in low and middl e-income
countries (Mathers et al. 2009). Vascular disease, includin g myocardial infarction and
stroke, is the predominant cause for adult death in China. The stroke mortali ty rate varied
from 116.63 per 100,000 per year for urban areas to 111.74 per 100,000 per year in
suburban areas in China. It constitutes 40% of all stroke-related deaths in developing
countries (Reddy et al. 1998; Wu et al. 200 I; Zhao et al. 2008).
Impact on health care: Stroke remains a substantial financial challenge for public health
care services . Stroke is the main cause of long-term disabil ity worldwid e, and 50% - 75%
of survivo rs live with stroke-related disabilitie s (Foulkes et al. 1988 ; Geddes et al. 1996;
Bonita et al. 1997; O' Mahony et al. 1999). Garo et al. (2000) performed a meta-analysis,
enrolling 1,446 ischemic stroke patients from 13 developed countries in the 1990s. This
study showed that the mean total cost of healthcare was US$ 14,000 per individual in the
first three months after a stroke, and the estimated lifelong cost per survivo r ranged from
US$59, 800 to US$230,000 in developed countri es. A total of US$65. 5 billion is estimated
to cover the total stroke-related costs in the United States for the year 2008 (Rosamond et
al. 2008). The European Heart Netwo rk (2008) reported that a total of E27 billion was
devote d to stroke-related fields in 27 European countries each year.
Geog raphical variation of stroke in China: One interesting phenom enon is the
geogra phical variation of stroke incidence in China. The SINO-MONICA project
registered stroke events in individuals aged between 25 to 64 years old in 16 provinces in
China from 1987 to 1993. The highest incidence was reported in the northern province of
Heilongjiang (337.7 and 553.3 per 100,000 per year for male and female, respectively),
while the lowest was in southern provinces such as Anhui (33.0 per 100,000 per year for
male) and Fujian (29.7 per 100,000 per year for female) (Wu et al. 2001). Other
epidemiology studies also documented the north - south gradient (Li et al. 1985; Wang et
al. 1985; Chen et al. 1993; Cheng et at. 1995).
The reason for the geogra phical diff erentiation remains unknown, but genetic factors
might play a role. The analysis of genetic markers on the Y chromoso me and
mitochondrial DNAs revea l that the Chinese Han population can be differenti ated into
northern Han and southern Han, geographically separated by the Yangtze River (Du et al.
1997; Wen et al. 2004 ). Recent genome-wide studies subdivided the Chinese Han into
northern, central and southern Han subgroups (Xu et at. 2009; Chen et at. 2009). The
Chinese Han population occupied Northern China area approximately 4,700 years ago,
the area from which the Han language and culture originated. Three massive migrat ions
from Northern to Southern China occurred during the western Jin Dynasty (AD 265-3 16),
the Tang Dynasty (AD 618-907) and the Southern Song Dynasty (AD 1127-1279 ),
respectively (Wen et al. 2004). The Han culture expanded into southern China, and
merged with southern natives (Fei et al. 1999, Ge et al. 1997). The southern Chinese Han
population subsequently developed (Wen et al. 2004). The genetic differenti ation of the
Chinese Han population will be further described in Chapter 2.
1.4Cascade of Ischemic Stroke
The availability of glucose and oxygen is crucia l for maintaining normal neurological
function. In ischemic stroke, the occlusion of cerebral arteries leads to a loss of blood
supply. The depletion of glucose and oxyge n causes functional and metabolic impairment
in the affec ted tissue. In cases where oxyge nated blood is entirely absent, the neurons will
undergo necrosis within eight minutes; however, in most ischemic strokes, collateral
vesse ls will complementarily supply blood to the lesion tissue, and the neuron cells in
marginal lesion locations can survive for up to five or six hours before irreversible
damage occurs (Adams and Victori a Neurology 8th).
Animal experiments (gerbil and rat penumbra models) indicate that the normal and
critical cerebral blood flow for brain metabolism and function are 0.55 L/g/min and 0.23
L/g/min, respectively (I-Iossmann et al. 1994). Once cerebral blood flow falls below 0.23
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L/g/min in the ischemic area, a cascade of multiple functional and metabolic changes will
occur at the molecular and cellular levels. These include ATP depletion, eft1ux of
potassium, influx of sodium and calcium, release of glutamate, accumulation of free fatty
acids, prostaglandin s, leukotrienes and free radica ls, degeneration of proteins and
membr ane disrupti on. All these changes finally trigger cell edema, necrosis and apoptos is
after several hours if effec tive intervention is not provided (Dimag l et al. 1999). When
cere bral blood flow is reduced below 0.12 L/glmin, the histological infarction lesion can
be identified (Hossmann et al. 1994).
1.5 Risk factors for Ischemic Stroke
According to the primary prevention guidelines established by the American Heart
Association!American Stroke Association Stroke Council (Goldsteine et al. 2006) , risk
factors for ischem ic stroke can be divided into modifiable and non-modifiable categories .
Modifiable risk factors can be controlled by a healthy life style or medication, while non-
modifiable risk factors include age, sex, genetic predisposition and ethnicity. Currently,
known risk factors account for only 60% of stroke, and the etiology of the remaining 40%
of cases remains undetermined (Whisnat et al. 1997; Donnan et al. 2008).
1.5.1 Modifiable Risk Factors
Hypertension
II
Hypertension, defined as systolic blood pressure (SBP) 140 mmHg or diastolic BP ~
90 mmHg, is an independent risk factor for stroke (Rosamond et al. 2007) . The number
of adults with hypertension was approximately 972 million worldwide in 2000, and is
estimated to reach 1.56 billion by the year 2025 (Kearney et al. 2005). Persistent
hypertension can lead to vascular endothelial damage , oxidative stress, altered vascular
tone and permeability, and the degeneration of vascular smooth muscle cells, all of which
contribute to stroke by aggravating atherosclerosis (Johansson et al. 1999). The severity
of hypertension is directly correlated with stroke risk (Lewington et al. 2002) . One
epidemiology survey estimated that 18.8% of adult Chinese (160 million individuals) are
hypertensive (Wang et al. 2005 ; Fang et al. 2006). A prospective observational survey
followed up on 5,092 male Chinese steelworkers for an average of 13.5 years. About 31%
of these participants were hypertensive, and a total of 87 (1.7%) individuals developed
ischemic stroke . Logistic regression analysis revealed that, for every ten mmHg rise in
systolic or diastolic blood pressure , there was an associated 1.4- or 1.8-fold higher risk for
stroke, respectively (Zhang et al. 2004) .
Diabetes mellitus
Diabetes mellitus refers to systematic metabolic syndromes characterized by persistently
increased plasma glucose levels due to a lack of insulin secretion or increased resistance
to insulin . According to the WHO (2006), a diagnosis of diabetes mellitus is made if any
12
of the following four situations is met: I) fasting plasma glucose 2:7.0 mmol/L; 2) plasma
glucose 2: 11.1 mmol/L two hours after a 75g oral glucose load; 3) symptoms of
hyperglycemia and casual plasma glucose level 2:11.1 mmol/L ; and 4) glycog lated
hemoglobin 2:6.5%. A meta-analysis including 39 countries estimated that 171 million
individ uals have been diagnosed with diabetes mell itus worldwide. This number is
expected to rise to 366 million by the year 2030 (Wi ld et ai. 2004).
Diabetes mellitus is an independent risk factor for first-ever stroke and accounts for 9.1%
of recurrent stroke (Stamler et ai. 1993; Burchfiel et ai. 1994; Petty et ai. 1998). Chronic
diabetes mellitus facilitates atheroscleros is by inducing endothelial dysfunction,
inhibi ting nitric oxide production and enhancing the proliferation of vascular smooth
muscle cells (Brown lee et ai. 200 I). About 15% to 33% of stroke patients have diabetes
mell itus (Hier et ai. 1991; Woo et ai. 1999; Hillen et al. 2003; Megherbi et al. 2003 ;
Karapanayiot ides et al. 2004). A meta-analysis of seven studies identifi ed that diabetes
mell itus conferred a 1.7-fold higher risk for ischemic stroke in patients with atria l
fibrillation (95%C I: 1.4 - 2.0). The annual stroke incidence varied from 2.0% to 3.5% in
indiv iduals with diabetes mellitus and atria l fibrillation (Stroke Risk in Atria l Fibrillation
Working Group, 2007). Diabetes mellitu s is also associa ted with increase d stroke
mortality and morbidity. Jia et al. (20 11) registered 14,526 hospitalized patients with
acute ischemic stroke and followed up on them for six months in China. They found that
27.0% of stroke patients had diabetes mellitus. A multivariate logistic regression analysis
illustrated that the prevalence of diabetes mellitus independently predicted higher risk for
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death or living dependency after stroke onset in the Chinese population (OR: 1.23; 95%
CI: 1.10 to 1.37).
Atrial Fibrillation
Atrial fibrillation denotes cardiac arrhythmia with chaotic electrica l signals generated
from the atria. Atrial fibrillation, which can enhance emboli formation via abnormal
hemostasis, endothelial dysfunction and increased platelet activation, accounts for
approximately 20% of ischemic stroke (Save lieva et al. 2007 ; Atrial Fibrillation
Investigators 1999). A cross-sectional study of 1.89 million adults in California screened
17,974 adults age ~ 20 years old with atrial fibrillation. It estimated that 2.3 million adults
have atrial fibrillation in the US, and 60,000 of these patients develop ischemic stroke
annually (Go et al. 2001) The Framingham study followed up on 5,070 individuals for
vascular events for 34 years. A total of 572 stroke events were recorded. Compared to
individuals without atrial fibrillation, individuals with this condition possessed a 2.6- 4.5
fold higher risk for stroke after adjustment for other cardiovas cular risk factors, such as
coronary heart disease, heart failure and hypertension (P<O.OO I)(Wolf et al. 1991).
Dyslipidemia
Dyslipidemia denotes derangement in lipid components, such as elevated total cholesterol
and triglycerides, and imbalance in lipoproteins, i.e., increased low-density lipoprot ein
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cholestero l (LDL-C) or reduced high-density lipoprotein cholesterol (HDL-C) .
Dyslipidemia triggers the atherosclero tic processes by inducing release of inflamm atory
factors, proliferation of smooth muscle cells, and dysfunction of endothelium and plaque
formation (Gau et at. 2006). Elevated total cholesterol, LDL-C, and triglycerides have
been reported to be assoc iated with increased risk for ischemic stroke, especially for the
large artery atherosclerotic stroke subtype (Iso et at. 1989; Leppala et at. 1999; Ebrahim
et at. 2006; Bansal et at. 2007; Freiberg et at. 2008; Bang et at. 2008). The associations of
fat and cholesterol intake with ischemic stroke were assesse d in the Chinese I-Ian
popul ation . Zhao et at. (2008) reported that ischemic stroke events increased by 8.7%
annually in the Beijing area from 1984 to 2004. Dyslipidemia was suggested to contribut e
to this upward trend . During the study period, fat intake increased from 88.1 g/d in 1983
to 97.4 g/d in 2002, and cholesterol intake from 334.5 g/d in 1983 to 488.4 g/d in 2002.
Studies in other populations also confi rmed this assoc iation. Koren-M orag et at. (2002)
followed up on 11,177 patients in Israel with coronary artery disease for eight years. A
total of 487 individuals developed ischemic stroke or transient ischemic attacks (TIA).
Logistic regression analysis showed that reduced HDL cholesterol (OR: 0.89, 95%C I:
0.81 - 0.98), elevated total cholesterol level (OR: 1.12, 95%CI: 1.03 - 1.23) and LDL
cholestero l (OR: 1.14, 95%C I: 1.00 - 1.26) were assoc iated with ischemic stroke or
transient ischemi c attacks (Koren-Morag et at. 2002).
Asymptomatic Caro tid Stenosis
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Asymptomatic carotid stenosis (ACS) is the presence of atherosclerotic plaque without
clinical manife stations . Emboli can break off from the plaque and block cerebral blood.
Stroke develops in such cases when persistent ischemi a occurs in the affec ted region. In a
prospective observational study, Norris et al. (199 1) followed 696 patients with
asymptomatic carotid stenosis. Annual stroke rates were 1.3% and 3.3% for patients with
carotid occl usion < 75% and 2: 75%, respectively. A cohort study in Toronto followed
106 patients diagnosed with asymptomatic carotid stenosis for ten years. Forty-eight
patients showed moderat e carotid stenosis <50%, while 58 patients showed severe
stenos is (2:50%). The ten-year risk of stroke was 5.7% in patients with moderate stenosis,
and 9.3% in patients with severe stenosis (Nadareishvili et al. 2002).
Hyperhomocysteinemia
Homocysteine is an intermedi ate product formed in methionine metabolism. Methionine
fi rst fo rms S-adenosylmethionine (SAM) by receiving adenosine from adenosine
triphosphate (ATP), then SAM demethylates to S-adenosy lhomocys teine (SAH) , which
donates adenosine to generate homocysteine. Homocystiene has two destinies in humans:
a) reversi ble rernethylation to methione via folate and vitamin 81 2, or b) irreversible
transsul furation to cystathionine by Vitamin 8 6 (Selhub et al. 1999). The normal plasma
homocysteine concentration in humans is < 15 umol/L. (Handy and Loscalzo 2003).
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The contribution of hyperhomocysteinemia to vascular disease was first proposed by
McCully in 1969, who reported a death from homocystinemia, cystathioninemia and
methylmalonic acidemia due to a defect in cobalamin metabolism (McCully 1969).
Arteriosclerosis was found at autopsy, which suggested that elevated homocysteine could
induce vascular endothelium damage. Elevated plasma homocysteine levels can induce
vascular damage through the following pathways: 1) facilitation of the atherosc lerostic
process by increasing vascular inflammatory mediator s ( Hofmann et al. 200 I ; Zhou et al.
2001 ); 2) impaired endothelial vasomotor function (E berhardt et al. 2000; Lentz et al.
2000; Dayal et al. 2001) ; 3) reduced bioavailability of nitric ox ide (NO) by inducing
vascu lar oxidative stress and elevating plasma asymmetric dimethylarginine (ADMA)
levels (Va llance et al. 2001; Weiss et al. 2001; Weiss et al. 2002; Ungvari et al. 2003 ;
Boger et al. 2003) ; and 4) dysregulation of lipid metabolism, inflammation and apoptos is
by inducing protein modification and endoplasmic reticulum stress (Lentz et al. 1991;
Lentz et al. 1993; Jakubowski et al. 2000; Austin et al. 2004 ).
Mild to moderate hyperhomocysteinemia (Hey = 15 - 100 umol/L) has been recognized
as an independent risk factor for vascular disease, includ ing ischemic stroke (Graham et
al. 1997; Welch et al. 1998; Rozen et al. 2000; Bersano et al. 2008). The Framinghan
study measured the total plasma homocysteine levels of 1,947 US part icipants (mean age
±S D: 70±7 years) and followed up for 9.9 years. One hundred atherothrombotic stroke
events occurred. Logistic regression analysis documented the association between
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hyperhomocysteinemia (greater than 14.2 umol/L) and antherothrombotic stroke (O R:
1.90, 95%C I: 1.02 - 3.5 1, P< 0.00 1) afte r adjustment for conventional vascular risk
factors (Bostom et al. 2003) . Other studies also confirmed the contribution of
hyperhomocys teinemia to ischemic stroke. Eikerlboom et al. (2000) compared the plasma
homocysteine level between 2 19 first-ever ischemic stroke patients and 205 age and
gender matched healthy individuals. The mean plasma homocysteine levels were 14.1
umol/L in patient s with large-artery ischemic stroke and 12.7 umol/L for those with
small-artery ischemic stroke, both of which were significantly higher than that found in
the control group (10.5 umol/L). Logistic regression analysis revealed that the upper
quart ile of the plasma homocysteine level (greater than 13.8l!mol/L) was associated with
increased risk for ischemic stroke (OR: 2.2, 95%CI: 1.1 to 4.2) compared to the lowest
quart ile group (homocysteine level less than 9.0 umol/L) after adj ustment for
conventional vascular risk factors. The associa tion of homocysteine levels with the large
artery subtype of ischemic stroke exhibited a dose-dependent pattern. Compared with the
lowest quartile of homocysteine (less than 9.0 umol/L), the ORs for large artery stroke
risk of the other three quart ile groups were 3.0 (95%CI: 0.8 to 10.8), 5.6 (95%C I: 1.6 to
20) and 8.7 (95%C I: 2.4 to 32), correspondin g to the second quartile (9.0 umol/L to 11.2
umol /L), the third quartile (1 1.3 umol/L to 13.8 umol/L) and the fourth quartil e (beyo nd
13.8 umol /L), respectively. A similar trend was observed in the Chinese Han population.
Li et al. (2003) measured the plasma homocysteine level in 807 cerebral thromb osis
patients, 513 small artery stroke cases and 1,832 age and sex-matched controls. The
median total plasma homocysteine levels were 14.7 umol/L in atherothrombotic stroke
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and 14.8 umol/L in sma ll artery stroke, respectively. Both of these were sig nificantly
higher than the median value of 12.8 umol/L found in the controls. Logistic regression
ana lysis indicated that the elevated homocysteine level was independentl y assoc iated with
athero thrombot ic stroke (OR: 1.72, 95%C I: 1.39 to 2.12, P<O.OOI) and sma ll artery
disease after adjusting for conventional vasc ular risk factors (OR: 1.89, 95%C I: 1.50 to
2.40, P<O.OOI) (Li et at. 2003).
Life style: cigarette smoking, nutriti on, obesity and physical inactivit y
Unhea lthy modem life styles, including smoking, poor diet , obesity and physical
inactivity, can impair the cardiovasc ular system and increase stroke risk.
Smoki ng, includ ing exposu re to a smoking enviro nment and active cigarette smoking, has
been recognized as a significa nt risk factor for ischemic stroke (Wolf et at. 1988 ; Mast et
at. 1998; Bon ita et at. 1999; Heuschm ann et at. 200 7). Cigare tte smoking can enhance
vasc ular inflammation, thromb osis and ox idation of LDL cholestero l (Ambrose and
Barua 2004). In a large, popul ation-based cohort study, Mannam i et at. (2004) observe d
19,782 males and 2 1,500 females aged from 40 to 59 years old, all of whom had no
history of vascular disease. Their smoking status and inciden ce of stroke were recorded
from 1990 to 2001. A total of3 27 and 176 ischemic stroke events occurred in male and
female indi vidual s, respectivel y. Compared to stroke patient s without a history o f
smo king, logistic regression analysis revealed that current smokers showe d a 1.66- fold
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(95%CI: 1.25 to 2.20) higher risk for ischemic stroke independent of conventional risk
factors. A similar trend was observed in other studies . Another prospective study enrolled
118,539 US female participants aged from 30 to 55 years old and without a history of
vascular disease, and were followed up on for eight years. A total of 122 thromb oembolic
stroke events were recorded. Data analysis indicated that current smokers consuming
more than 15 cigarettes per day conferred a 2.7-fold higher risk for ischemic stroke
compared to non-smokers (Colditz et al. 1988).
Excess intake of sodium can induce water retention in the cardiovascular system which
increases the risk for hypertension (He and MacGregor 2004). Recomm ended intake for
sodium and potassium are :52.3 g/d and ;:::4.7 g/d, respectively (Goldstein et al. 2006). A
19-year cohort study, including 2, 688 overwe ight individuals aged 25 to 74 years old,
revea led that a daily intake of extra 100 mmol predicted a 1.32- fold higher risk for stroke
(95%CI : 1.07 - 1.64, P < 0.0 1) (He et al. 1999). Another populat ion-based study
enrolling 43,783 middle-aged US male individuals reported a positive association
between potassium supplements and a reduced risk for stroke afte r eight years follow- up
(RR: 0.36, 95%C I: 0.18 - 0.72) (Ascherio et al. 1998).
Obesity, defined as body mass index (8 MI) >30 kg/rrr' , contributes to ischemi c stroke by
inducing endothelial damage and the proliferation of inflammato ry factor s in vessel s
(Poirier et al. 2006; Strazzullo et al. 2010). Kurth et al. (2002) enrolled 21,4 14 US male
physicians free of cardiovascular disease in 1982. A total of 63 1 (5.5%) ischemic stroke
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events were recorded in the subsequent 12.5 years. Compared to those with normal
weight (8 MI <23), obese individuals with a 8MI > 30 showed a 1.95-fold higher risk
(95%C I: 1.39 to 2.73, P < 0.00 I) for ischemic stroke. In addition to males, obesity also
confers a risk for ischemic stroke in females. A prospective cohort study enrolled 116,759
US female nurses aged 30 to 55 years old, who were free of cardiovas cular diseases, and
followed up for 16 years. Compared to normal weighted participants (8 MI< 27 kg/rrr'),
the relative risk ratios for ischemic stroke in overwe ight individual s were 1.75 (95%C I:
1.17 - 2.59), 1.90 (95%C I: 1.28 - 2.82) and 2.37 (95%C I: 1.60 - 3.50) for individual s
with 27 kg/rn'' S; 8MI S; 28.9kg/m2, 29kg/m2 S; 8MI S; 31.9kg/m2, and 8MI ~ 32kg/m2,
respectively (P < 0.00 I) (Rexrode et al. 1997).
Physical inactivity contributes to ischemic stroke by affecting vascular risk factors (Lee et
al. 2003). In a large population-based cohort, 39,3 15 US healthy individuals over 45 years
old were recru ited. During 11.9 years follow-up, 473 ischemic stroke events occurred.
Compare d to individuals with little physical activity «200 kcal/week), participants with
moderate (600 - 1,499 kcal/week) and high physical activity (~ 1,500 kcal/week) showed
a lower risk for ischemic stroke, OR ratios were 0.66 (95%C I: 0.52 to 0.84 ) and 0.61
(95%C I: 0.47 to 0.80) for moderate and high physical activity, respecti vely. Other studies
also provided evidence that regular physical activity has beneficial effects in reducin g the
incidence of ischemic stroke. Lee et al. (2003) analyzed 23 studies from 1966 to 2002,
and revea led that physical activity was assoc iated with a lower risk of stroke, showing a
2 1
20% reduction for moderate activity (RR = 0.80) and a 27% reduction for high strength
activ ity (RR: 0.73, 95%C I: 0.67 - 0.79), respectively, compared to low levels of activity.
1.5.2 Non-modifiable Risk Factors
Age
Adva nced age is a signific ant risk factor for stroke, resultin g in a 2-fo ld increased risk for
every ten years afte r the age of 55 years old, with two thirds of stroke patients being
grea ter than 65 years old (Wo lf et al. 1992; Senelick et al. 1994; Brown et al. 1996;).
Feig in et al. (2003), after perform ing a meta-analysis invo lving a total of 3.266 ,366
individuals from 13 countries worldwide, revealed the trend toward increase d stroke
incidence with adva nced age. The age-standard ized stroke incidence rate ranged from 0.1
to 0.3 per 1,000 person-years for individuals with an age less than 45 years old; 4.2 - 6.5
per 1,000 person-years for individuals aged greater than or equal to 55 yea rs old; and
inc idence increased to 12.0 - 20.0 per 1,000 person-years for elderly people aged greater
than 75 years old. Another meta-analysis reported that the stroke incidence was 30 times
higher in individuals beyond 75 years old, compared to individuals aged 35 to 44 years
old in the Chinese Han popul at ion (Li u et al. 200 7).
Sex
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Males are more vulnerable to stroke than females. The China Mult icenter Collaborative
Study of Cardiovasc ular Epidemiology in 17 communities across China from 1991 to
2000 showed that men acco unted for 59.0% of total stroke events among all 16,031
registered first-eve r stroke patients (~ 25 years old) (Zhang et al. 2003). An eight-yea r
national registry in Denmark aimed at hospitalized individuals with first-ever ischemic
stroke reported that males accounted for 52.1% of 40,102 individuals, and the incidence
rate was obviously higher in males than females among middle-aged individuals
(Andersen et al. 20 I0).
Race-Ethnicity
African Americans show higher stroke incidence than European Caucasians (Broderic k et
al. 1998). The reason for this might include higher prevalence of vascular risk factors
such as hypertension and diabetes in African Americans compared to Caucas ian and
Hispanic populations (Schca mm et al. 20 10). The prospective population-based Northern
Manhatta n Stroke Study (NOMASS) examined 210,000 residents in northern Manhattan
area . The study revea led that African Americans showed a 2-3 fold higher risk for
developing ischemic stroke per year compared to European descend ants (Sacco et al.
1998). A more recent Greater CincinnatilNo rthern Kentuck y population project
ascertained stroke events among 1.3 million residents in the study area in 1993, 1999 and
2005. The race-adjusted ischemic stroke incidence rates were 303, 29 1 and 294 per
100,000 persons for African Americans for the same periods, respectively. The incidence
rates for their European desce ndants were 206, 241 and 179 per 100,000 persons for the
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year 1993, 1999 and 2005, respectively. Comparison between the two ethnic groups
revealed that African Amer icans have a higher chance of developin g ischemic stroke than
Caucasian popul ations despite the declining trend in incidence with in eac h ethnic group
(Kleindorfer et al. 20 I0).
Genetic predisposition
The genet ic predisposition for stroke was identified in animal models. Rubattu et al.
(1996) crea ted a stroke-prone hypertension-ind ependent rat model by hybr idizing male
stroke-prone spontaneo usly hypertensive rats and female stroke-res istan t spontaneously
hypertensive rats . The researchers observe d stroke incidence among the 220
norm otensive rats and perform ed a genome-wide linkage analysis by genotyping a total of
1,038 genetic markers. Three quantit ative loci on Chromoso mes I and 5 showed LOD
scores > 3.0. This study indicated that genetic components contribute to stroke,
independent of hypertension .
Popul at ion studies sugges t that genetic component play a substantial ro le in ischemic
stro ke in humans. The nationwide twin study in Denmark recru ited 35 1 monozygoti c and
639 dizygo tic twins born from 1870 to 1952. At the initia l screening, one twin from each
pair was verified for stroke death , the cause of death in the other twin was then recorded
from the Register of Causes of Death or the Danish National Discharge Register. It
showed that monozygotic twins had a higher concordance rate (35 pairs, 10%) of stroke
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death compared to dizygotic twins (34 pairs, 5%) (OR: 2.1, 95%C I: 1.3- 3.3) (Bak et al.
2002) . This study provides evidence for genetic predisposit ion to stroke-related death.
The Sahlgrenska Academy study on the European Caucas ian popul ation in Swe den
registered 600 consecutive ischemic stroke patients with onset age < 70 years old and 600
age- and sex- matched contro ls. Comparison between cases and controls showed that the
first-degree fami ly history of stroke was associa ted with increased risk of ischemic stroke
(O R: 1.75, 95%C I: 1.26 - 2.43). Statist ical significa nce remained when performin g
similar analysis in three subtypes of ischemic stroke . The odd ratios were 1.88, 1.79 and
1.70 for large-vessel stroke (95%C I: 1.02 - 3.44) , small-vesse l stroke (95%C I: 1.13 -
2.84) and cryptoge nic stroke (95%CI: 1.13 - 2.56), respectively (Jood et al. 2003).
The mechanisms invo lved in genetic predisposition for stroke are proposed to involve the
following pathways: I ) genetic components facilitate the developm ent of conventio nal
vasc ular risk factors, such as hypertension and hyperhomocysteinemia, which increased
stroke risk in vulnerable individu als; 2) genetic comp onents interact with enviro nmental
factors to enhance stroke risk; and 3) genet ic components contribute to intermediate
phenotypes , such as atherosclerosis, which can lead to stroke (Dichgans et al. 200 7;
Stankovic et al. 20 I0). During the past two decades, dozens of candidate genes have bee n
reporte d to be assoc iated with stroke; however, few of these show consis ten t result s in the
studied popul ations. The candidate gene study of ischemic stroke will be discussed in
chapter 2.
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Chapter 2
Candidate Genes for Ischemic Stroke
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2.1 Single Nucleotide Polymorphi sm, Haplotype and Linkage Disequilibrium
Single nucl eotid e polymorph isms (SN P) refer to variation in DNA sequence caused by a
single nucl eotide (adeni ne, thymine, cytosine and guanine) variation at spec ific loci. The
human geno me is estimated to contain 6.0 million common SNPs (minor alle1e frequency
> 5%) (Da na et al. 2005) . Approxima tely 2.3 million SNPs differ between two unrelated
indiv iduals, i.e., I nucleotide variation per 1,000 - 2,000 base pairs (The International
SNP Map Work ing Gro up 200 1). When SNPs occur in the protein-coding region , they are
categorized into two types, depending on their effec ts on the resultin g polypeptid e
seque nces : (I) syno nymo us variation, in which the nucleotide variation does not change
amino acid sequence; and (2) non-synonymous varia tion, which result s in amino acid
change or premature termination. SNPs are usually biallel ic. The frequency of alleles can
vary geogra phically between different ethnic pop ulations: the major allele at a certa in
locus in a popul ation can be the minor one in another (Taras et al. 20 10).
In gene tic association studies, haplotype refer s to SNPs on different loci on the same
chro mosome statis tica lly associa ted with each other (The International HapM ap
Consort ium 2003 , 2005) . Linkage disequil ibrium descr ibes the non-r andom associa tion of
allele s on differe nt loci (Falco ner et al. 1996). Genetic linkage disequ ilibrium can help
identify candidate loci con tributing to diseases in case that the tested genet ic marker and
the disea se causing var iant are close ly linked (Briscoe et al. 1994 Plomin et al. 1994;
Jorde et al. 1995; Kaplan et al.1995; Chapman and Wijsman 1998). For two loci not
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tightl y linked , linkage disequilibrium will grad ually decay over generations for
recombination occurs between the two loci. For those closely linked loci , linkage
disequilibrium between disease and marker loci will remain strong throu gh generations.
These assumptions provide the basis for genetic assoc iation studies identifying candidate
genetic variants for diseases.
The International HapM ap Project categorizes the human genome into linka ge
disequilibrium (LD) block s, i.e., certain chromo some region s where allelic association
betw een SN Ps show s few historical recombination events (Tail on-Mill er et al. 2000 ; Daly
et al. 200 1). The identificati on of LD block s provides an efficient tool in genetic
associa tion studies. Tes ting tagSNPs, which represent these LD blocks, can avo id the
need to genotype all SN Ps within the candidate region (Risch et al. 2000; Zhang et al.
2002) . The LD patterns of more than 4.0 million SN Ps across the whole genome have
been charac terized in different ethnic popul ations following the compl etion of the
International HapM ap Project phase I and II in 2005 and 2007 (Chee et al. 20 I0) .
2.2 Candidate Gene Approach Study of Ischemic Stroke
The candidate gene approach study has been wid ely used in investigatin g genetic risk
factors for compl ex disease (Matarin et al. 2009) . SNP s are often used as genetic variant s
in these assoc iation studies. These SNPs are genotyped in subjects with the target
phenotype (cases) and age- and sex- match ed healthy indiv iduals (controls). The
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associa tion between the candidate variants and targeted disease can be assesse d by the X:
test ana lyzing the frequency difference between case and control groups. Odds ratios are
used to indicate the relative risk of the tested variants on disease (Sanja 20 I0). A reliable
genetic associatio n study requires a large sample size (> 1,000) with adjustmen t for age
and sex (Li et al. 2003).
2.3 Candidate Genetic Variant s in Ischemic Stroke
Genetic assoc iation studies have been widely applied to map common genetic variants
(minor allele frequency > 5%) conferring risk for stroke (Matarin et al. 2009). To date.
studies have revealed pathophysiological process of ischemic stroke are involved in the
following pathways: I. haemostasis system: factor V, factor VII, factor XII, factor XIII.
factor II (prothrombin), fibrinogen, plasminogen activator inhibitor- l , platelet
glycoprotei n receptors, von Willebrand factor, tissue plasminogen activator, thrombin
activable fibrinolysis inhibitor, thrornbomodulin, protein Z, and annexin AS ; 2.
homocysteine metabo lism: methylene tetrahydrofolate reductase, cystathione beta-
synthase, and methionine synthase; 3. lipid metabolism: apolipoproteins, lipoprotein
receptors, and key enzymes of plasma lipoprotein metabolism (Bersano et al. 2008,
Stankovic et al. 2010). The candidate genetic variants for ischemic stroke are summarized
in table 2. 1. The association between these candidate genetic variants and stroke remains
inconsistent in different ethnic populations (Matarin et al. 2009). The reason acco unting
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for this phenomenon may lie in selection bias, small sample size, and heterogeneity of
stroke. There fore , further studies are needed to help reso lve this debate.
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Table 2.1 Candidate genes for ischemic stroke (Adapted from Bernaso et at. 2008
and Stankovic et at. 2010)
Pathogenetic systems
I-1acmostasis
Homo cysteine metaboli sm
Lipid metaboli sm
Candidate genes
F2, F5, FGA/FG B, F7. FI 2A!, VWF ,
F12, SERPINE I, ITGB3, ITGA2B,
ITGA2, GPIBA, ACE, ACT
MTHFR , CBS, MTR
APO f:2, d , f:4, LPL, PON 1/2/3, CET P,
ABCA I
3 1
2.4 Genomewide Association Study of Stroke
A genome-wide association study (OWAS) is a method by which large numb ers of SNPs
evenly scattered throughout the whole genome are genotyped. It is expected to discover
novel genetic variants by providing a hypothesis-free method to inves tigate common
genetic variants with moderate effec ts on complex disease (KuI et al. 20 I0). So far ,
OWAS have identified severa l novel candidate genetic loci for ischemic stroke, including
4q25 (PlTX2 gene) (Gretarsdottir et al. 2008), 16q22 (ZFHX3 gene) (Gudbja rtsso n et al.
2008) and 12pl 3 (N/NJ2 gene) (Ikram et al. 2009). However, subsequent independent
validatio n studies have failed to reproduce these OWAS findings (Hegele et al. 20 10). In
addition, genetic variants for ischemic stroke identifie d by the candidate gene approac h
did not achieve the statistical significance level in genome-wide assoc iation studies
(Ikram et al. 2009) . Up to now, OWAS have not revolutionized the genetic study of
stroke as expected.
2.5 Candidate Genetic Vari ant s in the Present Stud y
2.5.1 MTHFR c.677C>T and c.l298 A> C variants
The assoc iation between hyperhomocysteinemia and stroke is described in chapter I.
5, 10-Methyleneterahydrofo late reductase (MT HFR), the key enzyme regulating
homocysteine metabolism, remethylates homocysteine back to methionine by catalyzing
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the reduction of 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofo late (Ueland et
al. 2000, 200 1; Champe et al. 2008). Impaired MTHFR activity interrupt s the
remethylation process of homocysteine to methionine, and the plasma level of
homocysteine subsequently accumulates leading to hyperhomocysteinemia.
The MT HF R gene, which is located on chromosome Ip36.3 and encodes the MTI-IFR
enzyme, has been widely investigated for its contr ibution to cardio vascular disease
(Goyette et al. 1994; Bersano et al. 2008; Stankovic et al. 2010). The most studied variant
is the MTHFR c.677C>T (p.Ala222Val) vairant. In vitro experimen ts indicated that
heterozygous CT and homozygous TT genotypes reduce MTHFR activity to 65% and
35% compared to the homozygous CC genotype. The homozygous TT genotype leads to
enzyme thermoliability and increases plasma homocysteine levels by 25% (Fross t et al.
1995). Van der Put et al. (1998) confirmed this phenomenon by comparing the
homocysteine level among differen t genoty pes of the ilvfTHFR e.677C>T variant in 186
individua ls. The number of individ uals with l\r r HFR c.677C>T genotypes was 44.0%
(n=82), 4 1.9% (n=78) and 14.0% (n=26) for CC, CT and TT genotypes. respectively. The
mean plasma homocysteine level was 18.4 umol/L in the T l' genotype. which was
significa ntly higher than that of the CC genotype (13.1umol/L). This sugges ts that the
MT HF R c.677C>T variant may confer risk to stroke via inf1uence on plasma
homocysteine levels.
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The associa tion between MTHFR c.677C>T and ischemic stroke remains inconsistent.
Cronin et al. (2005) analyzed 22 studies, recruit ing 4,740 ischemic stroke cases and 7,486
controls, and revea led a dose-dependent association between the MTHFR c.677C>T
variant and ischemic stroke. Compared to CC genotype, odd ratios were 1.18 for
heterozygous CT genotype (95%C I: 1.09 to 1.29, P<O.OOI) and 1.48 for homozygous 1'1'
genotype (95%C I: 1.22 to 1.8, P<O.OOI). Li et al. (2003) recruited 807 ischemic stroke
patients and 1,832 contro ls. The median plasma homocysteine level was significantly
higher in cases (14.7 umol/L) compared to controls (12.8 urnol/L), and increased risk for
ischemic stroke in the Chinese Han population (OR: 1.72, 95%C I: 1.39 - 2. 12, P < 0.(01 ).
In addition, the homozygous 1'1' genotype was found in 24.5% of cases, versus 2 1.7% in
contro ls (OR: 1.37, 95%C I: 1.06 to 1.78). This indicates that the TT genotype is
associa ted with increased risk for ischemic stroke. However, another assoc iation study in
the Singapore Chinese population did not confirm this associa tion (Low et al. 20 II ). A
recent meta-analysis, includi ng six meta-analyses and ten case-control studies, failed to
confi rm the assoc iation between the AfTHFR c.677C>T variant and ischemic stroke
(Bersano et al. 2(09).
Ano ther common variant, A1THFR c. 1298A>C (p.Glu429A la), was identified by
sequencing the coding region of AfTHFR in 86 individuals with an open neural-tub e
defect and 403 control subjects (Van der Put et al. 1998). They established an associa tion
between AC/CC genotypes and reduced MTHFR activity in isolated human lymphocytes.
However, the effec t of MTHFR c.1298A >C variant on plasma homocysteine levels
34
remains uncertain . Studies reported that this variant either did not affect the homoc ysteine
levels, or was associated with elevated or even reduced homocysteine levels (van der Put
et al. 1998, Friedman et al. 1999, Lievers et al. 200 1, Castro et al. 2003). Sazc i et al.
(2006) genotyped the MTHFR c.1298A>C variant in 92 ischemic stroke patients and 259
healthy contro ls from a Turkish Caucasia n population. The CC genotype distributed to
20.7% of cases, which was significantly higher than 8.1% in the control group (OR: 2.950,
95%C I: 1.504 - 5.786, P = 0.001). Han et al. (20 10) perform ed a similar study on 264
silent brain infarction patients and 234 controls in the Korean population . Heterozygous
AC genotype possessed 30.3% of cases compared to 21.8% of control individuals, and
increased risk (OR: 1.734, 95%C I: 1.13 - 2.66, P < 0.05) for silent brain infarction.
2.5.2 Chromosome 9p21 Locus
The chromoso me 9p2 1 locus has been identified to be assoc iated with a broad range of
vascula r diseases. Rs1333049, an SNP within the chromoso me 9p2 1 locus, was reported
to be assoc iated with increased risk of coronary heart disease in the large Wellcome Trust
Case Control Consortium (WTCCC) study (1,926 cases and 2,938 controls, OR = 1.37,
95%C I: 1.26 to 1.48, P = 1.80x I0- 1\ and was validated subsequently in the German
Myocardial Infarction Family Study (875 cases and 1,644 cont rols, OR=1.3 3, 95%C I:
1.18 to 1.51, P = 3.40x I0-6) (Samani et al. 2007) . A meta-analysis involving 12,004
patients with coronary heart disease and 28,949 controls confirmed the association
between rs1333049 and coronary heart disease in the Caucasian populati on (OR: 1.14,
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95%C I: 1.20 - 1.29, P=6.04 x I0-1o) (Schunkert et at. 2008) . Saxe na et at. (2007)
genotype d 386,73 1 SN Ps in 1,464 patients with Type 2 diabetes mellitu s and 1,467 age
and gender-matched controls, and found that the T allele of rs I081166 1 on chro moso me
9p2 1 locus distributed significa ntly higher in cases than in control s. (OR: 1.37, 95%C I:
1.18 - 1.59, P = 3.6 x10-5) . A subsequent cohort of 3, 167 Chinese Han individu als
replicated the enhanced risk of the variant rsl0811 661 conferring to Type 2 diabetes
mellitu s (OR: 1.23, 95%C I: 1.03 to 1.47, P = 0.02) (Cheng et at. 20 11). A large case
control study sugges ted that the G allele of rs107 57278 on chromosome 9p2 1 locu s is
assoc iated with abdominal aortic aneurysm (2,836 patients and 16,732 control s, OR : 1.31,
95%C I: 1.22 - 1.42, P=1.2 x 10-12) and intracrani al aneurysm (1,134 patient s and 15,481
contro l individuals, OR: 1.29, 95%C I: 1.16 - 1.43, P= 2.5 x10-6) (Helgadottir et at. 2008).
The associa tion betwee n 9p2 1 locus and ischemi c stroke represents one of the most
intriguing discoveries in the genetic study of ischemic stroke for the year 20 I0 (Mes chia
20 11). Mata rin et at. (2008) recruit ed 249 ischemic stroke pat ients and 268 contro ls from
a Ca ucas ian popul at ion . They identified that SNPs rsI 0116277, rs1333040 , rsl 333042
and rs2383207, which encompassed a 44-kb region on 9p2 1, were associated with
increase d risk for ischemic stroke (all P < 0.05). The assoc iation between this locus and
ischemi c stroke remains weak in the Chinese Han popul ation. Hu et a t. (2009) registered
355 ischemi c stroke patients and 430 healthy control s in the Beijing area. By genotyping
SN Ps rs2383206 and rsI 0757278 , this study identified that the AG/GG genotypes of
rs2383206 conferred a 1.51-fold higher risk for ischem ic stroke (95%C I: 1.11 to 2.05, P =
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0.009) , especially significant in large vessel stroke (OR: 2.09, 95%C [: 1.30 to 3.37, P =
0.002). However, the haplotype analysis did not reach sign ificance level (I' = 0.067). This
suggested that 9p2 [ confers a genetic risk for ischemic stroke in the Chinese Han
population. Ding et al. (2009) genotyped [7 tagSNPs on chromosome 9p2 [ in 558
patients with ischemic stroke, 510 patients with coronary artery disease and 557 contro l
individuals free of these conditions in the Chinese Han population. Their study showed
that rs2383206 (OR: 1.35, 95%C [: 1.11 to 1.64, I' = 0.006), rsl004638 (OR: 0.65,
95%C [: 0.53 to 0.81, I' = 0.001) and rs10757278 (OR: 1.39, 95%C I: 1.15 to 1.69, p=
0.002) distributed differently between coronary artery disease patients and control
individuals. However, none of the tested SNPs reached statistical signific ance level for
ischemic stroke in the study. Haplotype analysis revealed that the AITA haplotype of tag
SNPs rs2383206, rs1004638, rsl 7761442 and rs10757278 distributed 0.7% in ischemic
stro ke patients, significantly lower than in control subjects (4. 1%) (OR: 0.78, 95%C I:
0.67 to 0.87, P = 4.1 x 10""). Subsequent validation studies by the same research group
recruited 442 ischemic stroke patients and 502 contro l individuals. The above four SNJ>s
on 9p21 candidate locus were genotyped. Statistical analysis confirmed the above
associa tion at the haplotype level (OR: 0.85, 95%CI: 0.77-0.95 , 1'=0.003). However, no
statistica l significance was reached at the SNP level (Ding et al. 2009) . More
investigation s are needed on the association between chromoso me 9p2 1 locus and
ischemic stroke in the Chinese Han population.
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The 9p21 locus also conferred risk for several non-vascular diseases, such as open-an gle
glaucoma (Ramdams et al. 20 I0), melanoma (Bishop et al.20 I0), childhood acute
lymphoblastic leukemia (Sherborne et al. 2010), glioma (Shete et al. 2009), basal cell
carcinoma (Stacey et al. 2009) and breast cancer (Turnbull et al. 20 10).
The candidate locus on 9p21 is devoid of any known gene. Since these assoc iated SNPs
identifi ed in previous studies were common SNPs (minor allele frequency > 5% among
the studied population) from the initial GWAS SNP panel, scientists proposed that inter-
frequency variants (minor allele frequenc y varies at 2% - 5%), or those common SNPs
not included in the published data, might confer a higher risk for these phenotypes. Shea
et al. (20 11) then sequenced a 240-kb region on 9p21 in 47 individuals and established
536 novel SNPs includin g both common and inter-frequency variants. Two assoc iation
studies were performed on diabetes mellitus (1,000 type 2 diabetes patients and 1,048
contro ls) and myocard ial infarct ion (1,274 cases and 1,407 contro ls) by genotyping these
var iants . However, none of these newly established SNPs showed higher odds ratios
com pared with the published GWAS SNP signals.
Function studies have examined the effect of this locus on gene expressio n. Two tumor
suppresso r genes, cyclin-dependent kinase inhibitor 2A (CDKN2A) and CDKN2B reside
approximately 100 kb away from the core vascular disease risk region. The y are invol ved
in the regulation of cell cycle, aging, senescence, and apoptosis (Kim and Sharpless 2006;
Gil and Peters 2006). ANRIL is a non-coding RNA with its exons 13-19 overlapping the
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core vascular risk region on 9p21, and is transcribed in the opposite direction to the
CDKN2B gene. ANRIL is expressed in vascular tissues, such as coronary smooth muscle,
vascular endothelial cells, human monocyte-derived macrophages, carotid
endarterec tomy specimens, and abdominal aneurysm (Cunnington and Keavney 2011).
To date, function studies have revealed inconsistent results. Liu et al. (2009) identifi ed the
associa tion between rs10757278 on 9p2 1 and reduced expression of CDKN2A, CDKN2B
and ANRIL in periphe ral blood T lymphocytes from 170 healthy volunteers. Cunnington
et al. (2010) validated a similar association between chromosome 9p2 1 locus and
decreased ANRIL transcription in peripheral blood extracted from 487 healthy
indiv iduals. These studies suggested that chromosome 9p2 1 locus may contribute to
vascular disease by regulating expression of CDNKN2A, CDKN2B and ANRIL in vascular
tissues. However, other studies failed to confirm this associa tion (Michael et al. 2011).
Hold et al. (2010) revealed that chromosome 9p21 was associa ted with reduced ANRIL
and CDKN2B expression in mononuclear cells from 1,098 coronary artery patients.
However, this correlation dimini shed when testing the associa tion in atherosclero tic
plaque specimens. An animal study knocked out a 70kb on chromosome 4 in mice, which
was estimated to be orthologous to 9p21 in humans. These mice showed reduced
expressio n of CDKN2A and CDKN2B and proliferation of aortic smooth muscle cells.
However, they did not show a predisposition to vascular disease (Visel et al. 20 I0).
Another study sugges ted that 9p21 risk alleles contribute to vascular disease by increasing
platelet reactivity (Musunuru et al 2010). Musunuru et at (2010) identifi ed that 12 SNPs
in the 9p2 1 region showed an assoc iation with increased platelet reactivity among 1,402
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asymptomatic participant s (P<O.OOI). They also validated this association in the 2,363
participants from the Framingham heart study cohort. The exact mechanism underlying
the assoc iation between 9p21 and vascular diseases needs further elucidation.
2.6 The Genetic Complexity of the Chinese Han Population
China has the largest population worldwi de, with 1.3 billion individuals from 56 ethnic
groups. About 92% Chinese belong to the Han Chinese ethnic group, which constitutes
20% of the world's entire population. Genetic studies analyzing Y chromoso me and
mitochondrial DNA variations suggest that the Chinese Han population could be sub-
categorized into Northern Han and Southern Han, geographically divided by the Yangtze
River, the largest river running from west to east across China (Xiao et al. 2000; Wen et
al. 2004). A recent genomewide study, which mapped 160,000 SNPs in 1,700 individuals
from 22 regions across China indicated that the Chinese Han population could be further
differentiated into three subgroups: the Northern , Central and Southern Han (Xu et al.
2009) . Another larger study, genotyping 350,000 SNPs in over 6,000 partici pants
samp led from ten provinces, confirmed these genetic subgroups within the Chinese Han
population. They further indicated that the Chinese Han Beijing (CHB) population in the
international HapMap database could represent the Chinese Han from northern and
central areas (Chen et al. 2009). Our sample was collected solely from Henan province,
which is located in central China among 34 administrative regions in China.
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3.1 Rationale
Stroke is the second most common cause of adult death and is the leadin g reaso n for long-
term adult disability worldwide (Donnan et aL2008; Bonita et al. 2004). Assessment of
genetic predisposition will facilitate prevention and individualized treatment of stroke.
The assoc iation of MTHFR c.677C>T, c.1298A>C variants and 9p2 1 locus with ischemic
stroke is inconsistent in published data. The reasons for these inconsiste nt reports might
lie in the heterogeneity of stroke, genetic complexity between ethnic groups, or limits of
the study design.
The Chinese Han population, a seemingly homogenous ethnic population, has been
classifi ed into three geogra phic subregions: the North Han, Central Han and South Han
(Chen et al. 2009, Xu et aL 2009). Genetic variants assoc iated with complex disease
might be diff erent in these subpopulations; therefore, sample selection should be area
specific. The present study focuses on the Chinese Han population from Henan province,
the central China.
3.2 Objectives
In the present study, we performed two case control studies, with the following aims:
To assess the associa tion between two common variants, MTHFR c.677 C>T and
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c.1298 A>C, and ischemic stroke in the Chinese Han population from Henan
province ;
To investigate the genetic association between the candidat e chromos ome 9p21
locus and ischemic stroke in the Chinese Han population from Henan province.
3.3 Materials and Methods
From February 2006 to March 2007,1 ,429 consecutive patients (Mean age ± SO: 62.71 ±
11.80, male : n=868, 60.7%), diagnosed with ischemic stroke from 18 hospitals in Henan
province, were enrolled in the present study. The inclusion criteria were: I) stroke
diagnosis according to WHO criteria, and 2) an MRI or CT scan indicating the ischemic
lesion corres ponding to the neurological deficit s. Patients with hemorrhagic stroke,
subarachnoid hemor rhage, transient ischemic attack and severe systemic diseases were
exc luded from this study. The control group consisted of 1,197 (Mean age ± SO: 58.51 ±
9.237, male: n=760, 63.5%) ethnic matched individuals without a history of myocardial
infarction or stroke who were admitted to these hospital s for routine health examinations.
Informed consent was obta ined from all participant s. Samples were collected by the
Genetics department of Zhengzhou University. The study protocol on the collaboration
between Zhengzhou University and Department of Laborator y medic ine in Health
Sciences Centers, Newfoundland and Labrador , was approved by institution al boards.
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SNP Genotyping
Genomic DNA samples were obtained by salt extraction protocol (Miller et al 1988). In
the MTHFR study, two variants were tested, includin g MTHFR c.677C>T (rs I801133,
C_ 1202883_20) and MTHFR c.1298A>C (rs I801131, C_ 850486_20) variants. For the
9p2 1 study, four SNPs were selected from Chromosome 9p21.3 locus: includin g
rs l3330 49 (C_ 1754666_ 10), rs2383207 (C_15789010_ 10), rs10757274
(C_26505812_ 1O), and rs10116277 (C_ 2999 1625_20), which encompassed the 44-kb
candidate region on chromosome 9p2 1 (the position mapped to chr9.22071 397 and
chr9.22 115503). All tested SNPs were genotyped using TaqMan SNP genotyping kit
(ABI; Foster City, CA) on real-time PCR platform (ABI Prism 7000 sequence detection
system). The reaction volum e included: 2.0 III genomic DNA (100 ng/ul) , 2.5111 TaqMan
universal PCR master mix, 0.125 III primer and probes, 0.375 III ddH20. The standard
reaction condition included activation of uracil-N-gl ycolase (UNG) (2 min, 50°C) ,
polymerase activation (lOmin ; 95°C) , 40 cycles of denaturation (l5 s; 95°C), annealing
and extension ( Imin; 60°C) .
Statistica l Analysis
The genotype frequency data for each variant in the control group was tested for deviation
from the Hardy-Weinberg equilibrium using online software (http://ihg.gsf.de/cg i-
bin/hw/hwal.pl). Haplotype frequencies were estimated using the PowerMa rker V3.25
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Softwa re. Genotype and haplotype distributi on between case and control groups were
tested by the X2 test under recessive, dominant and co-dominant models by SPSS 16.0
softwa re package (SPSS Inc.). Statistical power was calculated using QUANTO V1.2.3
software . Differenc es with P< 0.05 (two-tailed) were considered statistically significant.
Bonferroni correction was not performed in the two studies due to the following reasons:
I) for the MTHFR study, two tested variants of the MTHFR gene are in linkage
disequil ibrium ; 2) for the 9p21 study, the four variants are from one candidate risk region,
where rs10757274 and rs2383207 are in one LD block, and two other variant s adjacent to
this block ; 3) Bonferroni correction is too conservati ve.
45
RiskwithAssociatedInterval
Chapter 4
Reduction of Chromosome 9p21 Locus
for
Ischemic Stroke in the Chinese Han
Population
Shuo Lil,2, Yu-Min g Xu5, Edward Randell' , Hong Zheng", Hai-Zheng Wang", Guang
Sun", Fei-Yu Han l,2, and Ya-Gan g Xic l,2,3,4
Discipl ines of 'Laboratory Medicin e, 2Genetics, 3pediatrics, and "Medicine, Memori al
University of Newfoundland , St. John ' s, NL, Canada,
Departm ents of 5Neurology of the First Affiliated hospital, and 6Genetics , Zhengzhou
University, Henan , P,R, China,
This manuscript has not yet been submitted/or publi cation.
46
Abstract
Background: Chromosome 9p21 common variants are strongly associated with coronary
arterial disease (CAD). This association has been expended to other vascular disorders
including ischemic stroke in Caucasians. However , the association between 9p2 1
common variants and ischemic stroke in the Chinese Han population lacks strong
evidence. Method: Four common variants, rs1333049, rs2383207, rsI0757274 , and
rs I0 116277 were selected from the 44 kb candidate region on chromoso me 9p2 1 locus.
We genotyped these SNPs in 1,429 ischemic stroke patients and 1,191 controls from the
Chinese Han population by using the TaqMan SNP genotyping technology on a real-time
PCR platform. Results : Heterozyous AG and homozygous GG genotypes of rs2383207
conferred a increased risk for ischemic stroke in the present study (P<0.05). Haplotype
analysis of rs10757274 and rs2383207 showed that the G-A haplotype was assoc iated
with significantly lower risk with ischemic stroke (OR: 0.359, 95%C I: 0.256 to 0.504,
P<O.OOI). Conclusion : A candidate region on 9p21 locus is assoc iated with ischemic
stroke in the Chinese Han population both at SNP and Haplotype levels. Our study
reduces the candidate region to 28 kb in the Chinese Han population.
Introduction
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Stroke is defined as acute focal or global neurologi cal deficits persisting more than 24
hours, or interrupted by intervention or death within 24 hours, with a presumed vascular
cause (W HO 1990). 9 million individuals are estimated to suffer from stroke each year,
and approximately 1.5- 2 million of these patients reside in China (Liu et a12007, Zhao et
al 2008, Meretoja 2011). Stroke is the second most common cause of adult death
worldwide, and about 5.4 million individuals are estimated to die of stroke-related events
each year, accounting for approximately 10% of total deaths worldw ide (Murray et al
1997, Donnan et ai, 2008 Bonita et al, 2004). Two-third s of stroke related deaths occur in
developing countr ies, with approximatel y 40% occurrin g in China (Geneva: World
Health Organization. 1998, Reddy et al 1998, Feigin et al 2003,).
Stroke is a complex disease to which both genetic and environmental factors contribute .
Common variants in a candidate chromosome 9p2l locus have recently been associated
with increased risk for coronary arterial disease (CAD). The 9p21 locus was first
identified as a genetic risk factor in CAD by four parallel genome-wide association
studies (The Wellcom e Trust Case Control Consortium 2007 ; Helgadottir et al. 2007;
McPherson et al. 2007; Samani et al. 2007). Subsequently , genome-wide assoc iation
studies have also demon strated the assoc iation between this locus and other vascular
diseases, including diabetes mellitus, abdominal aortic aneurysm, and intracranial
aneurism (Saxe na et al 2008, Helgadottir et al. 2008). Matarin et al. (2008) documented
that common variants from a 44-kb core candidate region on 9p21 were associated with
ischemic stroke in a Caucas ian population. However, replication studies in the Chinese
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Han population have revealed weak associa tion between 9p21 and ischemic stroke (I-Iu et
al. 2009 , Ding et al. 2009) . This may be due to a relatively small sample size and genetic
heterogeneity among the Chinese Han population. In the present study, we performed a
large case control study to replicate the association between the core candidate 9p21
region and ischemic stroke in the Chinese Han population.
Materials and Methods
Subjects
From February 2006 to March 2007, 1,429 consecutive patients (Mean age ± SO: 62.7 ±
11.8, male: n=868, 60.7%), diagnosed with ischemic stroke from 18 hospitals in Henan
provi nce, were enrolled in the present study. The inclusion criteria were: 1) stroke
diagnosis acco rding to WHO criteria , and 2) MRI or CT scan indicating the ischemic
lesion corresponding to the neurological deficits. Patients with hemorr hagic stroke,
subarachnoi d hemorrhage, transie nt ischemic attack and severe systemic diseases were
excluded from this study. The control group consisted of 1,197 (Mean age ± SO : 58.5 ±
9.2 male: n=760, 63.5%) ethnically-matched indiv iduals without history of myocardial
infarction or stroke who were admitted to these hospitals for routine health examinations.
In formed consent was obtained from all participants. Peripheral blood samples were
collected from patients and controls by the Genetics Department of Zhengzhou University.
The study protocol on the collaboration between Zhengzhou University and Department
of laboratory medicine, Health Sciences Centers, Newfoundland and Labrador was
approve d by institutional boards.
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SNP Genotyping
Genomic DNA was extracted from peripheral blood samples by using a standard salt
precip itation method (Miller et al. 1988). Four SNPs, rs1333049 (C_1754666_l0),
rs2383207 (C_ l 5789010_10), rs10757274 (C_265058I2_ 10) and rs1011 6277
(C_2999 1625_20) were selected from a 44-kb candidate region on chromosome 9p2 l
(chr 9.22071397-chr 9.22115 503). SNP Genotyping was performed using the TaqMan
SNP genotyping technolo gy on a real-time PCR platform (ABI Prism 700 sequence
detection system). The reaction volume included: 2.0 III genomic DNA ( lOOng/ill), 2.5 III
TaqMan universal PCR master mix, 0.125 III primer and probes, and 0.375 III ddH20.
The standard reaction condition included the activation of uracil-N- glycolase (UNG) (2
min; 50 °C), polymerase activation (IOmin; 95°C), 40 cycles of denaturation (15s; 95°C),
annealing and extension ( I min; 60 °C).
Statistical Analysis
The genotype frequency data for each variant in the control group was tested for deviation
from the Hardy-Weinber g equilibrium using online software (http ://ihg.osCde/cg i-
bin/hw/hwa 1.pl). Haplotype frequencies and association of haplotypes for case and
control status were estimated using the PowerMarker V3.25 Software. Genotype
frequencies and haplotype distribut ion between case and control groups were tested by
the X2 test under recessive, domin ant and co-dominant models by the SPSS 16.0 software
50
package (SPSS Inc.). Statistical power was calculated using QUANTa V1.2.3 software,
Differences with P< 0.05 (two-tailed) were considered statistically sign ificant.
The minor allele frequencies (MAF) of the four tested SNPs ranged from 0.31 to 0.49,
according to HapMap CHB (Chinese Han Beij ing) data, with a mean MAF of 0.40 for the
four SNPs. Given the disease prevalence at 0.5%, 1,429 patients and 1,197 controls
yielded a statistical power > 0.8 to detect an OR of 1.50 for the MAF of 0.40 for the
tested SNPs at a significance level of 0.05 (two-tailed) under recessive, dominant and
additive models. The software QUANTa version 1.2.3 was used for the calcul ation of
statistical powe r.
Results
The physical locations of the four studied genet ic variants (rs13330 49, rs238320 7,
rs10757274, and rs10116277) within the 44 kb core candidate region for stroke are given
in Figure 4.1. Four selec ted genetic variants were genotyped in 1,429 patients and 1,191
controls. The distributions of all possible genotypes for each variant are given in Table
4.1. The genotype frequencies of all four genetic variant s in the control subjects were all
under the Hardy-Weinberg equilibrium (all P>0.05 ).
The result showed that the AG / GG genotypes of SNP rs2383207 were associated with
increased risk for ischemic stroke (OR: 1.417, 95%C I: 1.123 to 1.786, P= 0.003), with
5 1
OR at 1.382 (95%C I: 1.081 - 1.766) and 1.417 (95%C I: 1.123 - 1.786) for heterozygous
AG and homozygous GG genotypes, respect ively. According to the data from HapMap
CHB (Chinese Han Beijin g), the rs10757274 and the rs2383207 are within one LD block
(r2 > 0.8), and the rs1333049 and the rs10116277 are scattered into two flankin g LD
blocks, respectively. None of the other three SNPs achieved a signifi cance level in the
present study, which indicates a smaller interval of the candidate region «28 kb) in the
Chinese Han populati on compared with the one (44 kb) previously reported in Caucas ians
(Matarin et al. 2008).
In the haplotype frequency analysis, only rs I0757274 and rs2383207 were included
because these two variants are in the same LD blocks. The distributi ons of all four
possible haplotype frequencies for rs10757274 and rs2383207 are given in Table 4.2.
Among the four possible haplotypes, the G-A haplotype was assoc iated with significantly
lower risk for ischemic stroke (OR: 0.359, 95%C I: 0.256 to 0.504, P<O.OOI), which
suggests a protective haplotype in the studied population.
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Table 4.1 Genotype distributions of rsl0116277, rsl0757274, rs2383207, and
rs1333049 in stroke and control subjects in the Chinese Han population
Genotype Stroke NC OR (95%C I) P-value
(n=I,429) (n=I,191)
Rs10116277
GG 137(9 .6%) 137(11.5%)
GT 606(42.4%) 501(42 .1%) 1.210 (0.928-1.576) 0. 159
TT 686(48 .0%) 553(46.4%) 1.241 (0.955 -1.612) 0.106
GT+TT 1292(90.4%) 1054(88.5%) 1.226 (0.954-1 .575) 0.111
AlleleF.
G 30.8% 32.5%
T 69.2% 67.5% 1.084 (0.964 - 1.218) 0.176
Rs10757274
AA 453(31.7%) 354(29 .7%)
AG 676(47 .3%) 600(50.4%) 0.880 (0.737-1.051) 0.159
GG 300(21.0%) 237(19 .9%) 0.989 (0.794- 1.232) 0.923
AG+GG 976(68.3%) 837(70 .3%) 0.911 (0.771-1.077) 0.275
AlleleF.
A 55.4% 54.9%
G 44.6% 45 .1% 0.982 (0.881 - 1.096) 0.749
Rs2383207
AA 154(10 .8%) 174(14.6%)
AG 642(44 .9%) 525(44.1%) 1.382 (1.081-1.766) 0.010
GG 633(44.3%) 492(41.3%) 1.454 (1.136-1.86 1) 0.003
AG+GG 1275(89 .2%) 1017(85.4 %) 1.417(1.123 -1.786) o.oo.
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Genotype Stroke NC OR (95%CI) P-value
(0= 1,429) (0=1,191)
AlleleF.
A 33.2% 36.6%
G 66.8% 63.4% 1.162 (1.037 - 1.302) (J.()] 0
Rs l 333049
GG 381(26.7%) 334(28.0%)
GC 733(5 1.3%) 571(47.9%) 1.125 (0.937-1.352) 0.206
CC 315(22.0%) 286(24.0%) 0.966 (0.777-1.200) 0.752
GC+CC 1048(73.3%) 857(72.0%) 1.072 (0.902-1.274) 0.429
Allelc F.
G 52.3% 52.0%
C 47.7% 48.0% 0.988(0.886 - 1.102) 0.832
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Ta ble 4.2 Distribution of haplotype frequency estimation for rs l 0757274 and
rs2383207 in ischemic stroke and contro l subject s
Haplotype Stroke NC OR (95%CI) P-value
Frequencies (2n=2 ,858) (2n=2 ,382)
rs10757274 -
rs2383207
A-A 898 750
A-G 683 555 1.028 0.717
(0.886- 1.192)
G-A 52 121 0.359 <0.00 1
(0.256-0.504)
G-G 1225 953 1.074 () . ~8()
(0.944-1.221)
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Discussion
In the present study, four variants, rs1333049, rs2383207, rs I0757274, and rs10116277
selected from the core candidate locus on chromoso me 9p2 1, have been genotyped in
1,429 ischmic stroke patients and 1,191 controls from the Chinese Han population. The
present study has shown that the G allele of rs2383207 on chromosome 9p2 1 locus is
assoc iated with ischemic stroke in the Chinese Han population. Interestedly, none of the
other three SNPs selected from the flanking LD blocks and the LD block encompass ing
the rs2383207 showed an assoc iation with ischemic stroke in the present study which
further narrowed down the interval of the candidate region from the previously reported
44 kb to an interva l less than 28kb. This finding will help further charac terize the
candidate 9p2 1 region and fina lly identify the critical DNA variation associa ted with
cardiova scular diseases . Haplotype frequency analysis pinpoints the G-A (rs I07572 74-
rs2383 207) haplotype as a protective haplotype for ischemic stroke in the Chinese Han
popu lation.
The assoc iation between 9p2 1 candidate region and cardiovasc ular diseases, i.e., coronary
artery disease and type 2 diabetes mellitus, was validated in the Chinese Han population
(Ding et al. 2009, Chang et al. 2011). However, the evidence for the assoc iation between
9p2 1 locus and ischemic stroke is rather weak in the Chinese Han population . I-1u et al.
(2009) genotyped rs23832 06 and rs10757278 from the core risk region on 9p2 1 in 355
patie nts with ischemic stroke and 430 controls. In this study, the G allele (AG/GG
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genotypes) of rs2383206. a SNP 933 bp away from rs2383207, conferr ed a 1.51-fold
higher risk for ischemic stroke in the Chinese Han population (95%C I: 1.11 to 2.05, P =
0.009) . The variant rs2383206 is only 933 bp away from rs2383207, and these two
variants are known to be in a same LD block in Chinese Han population. Another
association study between 9p21 locus and ischemic stroke was conducted using the
Chinese Han population in which 17 tagSNPs across 58 kb on the 9p2 1 region, includin g
the rs2383206, were genotyped in 558 patients and 557 controls (Xu et al. 2009). This
study did not validate the association between 9p21 locus and ischemi c stroke at the SNP
level. The inconsistent results may be due to either the relatively small sample size or
genetic heterogeneity in the studied Chinese Han population. The Chinese Han population
has been sugges ted to be genetically differentiated into three subgroups: the Northern ,
Central and Southern Han (Xu et al. 2009; Chen et al. 2009) .
So far, there is no coding seque nce identified within the core candidate region on the
chromoso me 9p2 1 locus. Two tumor suppressor genes, cyclin-dependent kinase inhibitor
2A (CDKN2A) and CDKN2B reside approximately 100 kb away from the core vascular
disease risk region. ANRfL is a non-coding RNA with its exons 13-19 overlapping the
core vascular risk region on 9p21, and is transcribed in the opposite direction to the
CDKN2B gene. Function studies revealed inconsistent results regarding the association
between the risk alleles on the core candidate region and expression of CDKN2A,
CDKN2B and ANRfL (Liu et al. 2009; Cunnington et al. 2010; Hold et al. 2010; Michael
et al. 20 II ). An animal study knocked out a 70kb sequence of chromoso me 4 in mice,
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which was estimated to be orthologous to 9p21 in humans. These mice showed reduced
expression of CDKN2A and CDKN2B and proliferation of aortic smooth muscle cells.
However, they did not show a predisposition to vascular disease (Visel et al. 20 10).
Another study sugges ted that 9p21 risk alleles contribute to vascular disease by increasing
platelet reactivity (Musunuru et aI20 10).
Concl usion
The prese nt study validates the assoc iation between 9p2 1 and ischemi c stroke in the
Chinese Han population. The exac t mechanism underlying the assoc iation of 9p2 1 with
vascular diseases needs further elucidation.
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Abstract
Background: Two common variants, MTHFR c.677C>T and c. 1298A>C, have been
extensive ly studied for association with ischemic stroke. Previous studies revealed
discordant results. Method: Genotyping of MTHFR c.677C>T and c.1298A>C was
performed on 1,429 consecutive patients with ischemic stroke and 1,171 ethnically and
gender matched healthy controls by using TaqMan SNP genotyping technology on real-
time PCR. Results : The MTHFR c.677T allele was interestingly found to be the major
allele in the studied Chinese Han population with an allele frequency of 59.5%.
Moreover, the MTHFR c.677T allele showed a significantly higher allele frequency (OR:
1.245, 95%C I: 1.112 to 1.393, P<O.OOI), and higher heterozygote (OR: 1.474, 95%C I:
1.170 - 1.858, P=O.OO I) and homozygote prevalence (OR : 1.642, 95%C I: 1.296 to 2.080,
P<O.OOI) in ischemic stroke patients. For the MTHFR c.1298A>C variant, the
heterozygous AC genotype exhibited a lower risk for ischemic stroke (OR=0.803,
95%C I: 0.664 to 0.970, P=0.023). Permutated haplotype analysis showed that the 6771'-
1298A haplotype was associate d with a 1.I 38-fold increased risk for ischemic stroke
(OR; 1.138, 95%C I: 1.003 to 1.292, P = 0.045). Conclu sion : The results of the present
study sugges t that MTHFR is associa ted with ischemic stroke in the Chinese Han
population. MTHFR c. 677C>T is a risk variant, and its effect could be modifi ed by
genet ic or environmental factor(s) which vary among different ethnic populations. The
MTHFR c.1298A>C variantjs more likely to play the role of a genetic marker than
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causative variant in associa tion with ischemic stroke. The MTHFR c. 677T-1298A is a
risk haplotype for ischemic stroke in the Chinese Han population.
Introduction
Stroke is the second most common cause of adult death and the main cause for adult
disability worldwide (Bonita et al. 2004). The incidence of stroke in Chinese is 1.5 - 2.0
million per year (National 8.5 collaborative Group 1985, Shi et al 1989), with an obvious
geographical trend increasing from south to north, approximately divided by the Yangtze
River (Li et al 1985, Chen et al 1993). Among cardiovasc ular disorders, stroke accounts
for the highest mortality rate in the Chinese Han population, three times higher than
myocar dia l infarction (Li et al. 2003) .
Methylenetetrahydrofolate reductase (MTHF R) is essential for homocysteine metabolism
( Frosst et al. 1995) . Mild to moderate hyperhomocysteinemia ( IS - 100 umol/L) has
been cons idered as an independent risk factor for ischemic stroke (Graham et al. 1997,
Rozen et al. 2000, Bersano et al. 2008) . Two common variants in the coding region of the
MTHFR gene, MTHFR c.677C>T (p. Ala222Va l) and c.1298A>C (p. Glu429A la), have
been reported to be prevalent in North American, European and Asian populations (Botto
et al. 2000 ; Guillen et al. 200 1; Castro et al. 2003; Kohara et a12003; Li et al. 2003; Kim
et al 2007). The MTHFR c.677 C>T variant was reported to be associa ted with impaired
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MTHFR enzyme activity and elevated plasma homocysteine levels (Fross t et al. 1995.
Van der Put et al. 1998). The MTHFR c.1298 A>C variant was shown to be associa ted
with reduced MTHFR activ ity in in vitro experi ments (Van der Put et aI.1998). However,
studies on the effect of this variant on plasma homocysteine levels remain controve rsial
(We isberg et al. 1998, Yamada et al. 2001) . The association between MTHFR c.677C>T,
c.1298A >C variants and ischemic stroke has revealed inconsistent results in different
ethnic populations. (Casas et al. 2001, Pezzini et a12002, Li et al. 2003, Sazc i et al. 2006,
Kim et al. 2007, Oichgans 2007). Therefore, the assoc iation between the two variants and
ischemic stroke has not been clearly established and continues to be the subjec t of debate.
Etiologies of complex disease usually involve genetic and environmental factors . The
gene tic mixture within a population could complicate results due to heterogeneity among
genetic modifiers. To minim ize these effects, we undertook a case control study by
enrolling 1,429 ischemic stroke patients and 1,197 controls from the Chinese Han
population to investigate the genetic effec ts of the MTHFR c.677C>T and c. 1298A>C
variants on stroke.
Material s and Method s
Subjects
From February 2006 to March 2007, 1,429 consecutive patients (Mean age ± so: 62.7 ±
11.8, male: n=868, 60.7%), diagnosed with ischemic stroke from 18 hospitals in Henan
province, were enro lled in the present study. The inclusion criteria were : I) stroke
diagnosis accor ding to WHO criteria, and 2) an MRIor CT scan indicating an ischemic
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lesion corres ponding to the neurological deficits. Patients with hemorrhagic stroke,
subarachnoid hemorrhage, transient ischemic attack and severe systemic diseases were
excl uded from this study. The control group consisted of 1,197 (Mean age ± SO: 58.5 ±
9.2 male: n=760, 63.5%) ethnically matched individuals without a history of myocardi al
infarction or stroke who came to these hospitals for routine health examinations.
Informed consent was obtained from all participants. Samples were collected by the
genetics department of Zhengzhou University. The study protocol on the collaboration
between Zhengzhou University and Department of laboratory medicine, Health Sciences
Centers, New foundland and Labrador, was approved by institutional boards.
Genotyping of the MTHFR c. 677C>T and c.1298A>C variants
Genomic DNA samples were obtained by salt extraction protocol (Miller et al 1988). The
two varian ts, MTHFR c.677C>T (rs I801133, C_ 1202883_20) and MTH FR c.1298A>C
(rs I801131, C_ 850486_20) were genotyped using a TaqMan SNP genotyping kit (ABI;
Foster City, CA) on a real-time PCR platform (ABI Prism 7000 sequence detection
system). The reaction volume included: 2.0 III genomic DNA (100 ng/ul ), 2.511 Taq Man
universal PCR master mix, 0.125 III primer and probs, 0.375 III ddH20 . The standard
reaction condition included: activation of uracil-N-glycolase (UNG) (2 min, 50°C),
polymerase activation ( IOmin; 95°C), 40 cycles of denaturation (15s; 95°C) , annealing
and extensio n ( Imin; 60°C) .
Stat istica l Analysis
64
The genotype frequency data for each variant in the control group was tested for deviation
from the Hardy-Weinberg equilibr ium using online software (http ://ihg .gsf.dc/cgi-
bin/hw/hwal.pl). Haplotype frequencies were estimated using the PowerMarker V3.25
Software . Genotype frequencies and haplotype distribution between case and control
group s were tested by the X2 test under recessive , dominant and co-dominant models by
the SPSS 16.0 software package (SPSS Inc.). Statistical power was calculated using
QUANTa V1.2.3 software. Differences with P< 0.05 (two-tailed) were considered
statistically significant.
Results
A total of 1,429 patients and 1,171 controls were successfully genotyped for both
variants. The genotype frequencies for the MTHFR c.677C>T and c.1298A >C variants in
the control group did not deviate from the Hardy-Weinberg equilibrium (P>0.05).
MTHFR c.677C>T and c.1298A>C variants frequency distribution
The distribution of genotype and allele frequencies for each variant between patients and
controls are shown in Table 5.1. In terms of the MTHFR c. 677C>T variant, the T allele
has been found to be the major allele in the studied Chinese population with a frequency
of 59.5%. In comparison with the controls , the T allele in ischemic stroke patients was
significantly higher (OR: 1.245, 95%CI : 1.112 to 1.393, P<O.OOI).Heterozygous CT and
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homozygous TT genotypes showed association with increase risk for ischemic stroke,
with OR of 1.474 (95%C I: 1.170 - 1.858, P = 0.001) and 1.642 (95%CI: 1.296 - 2.080,
P<O.OOI) for heterozygo us CT and homozygous TT, respectively. For the MTHFR c.
I298A >C variant, the heterozygous AC genotype associated with lower risk for ischemic
stroke (OR: 0.815, 95%C I: 0.664 - 0.970, P=0.023).
Analyses of estimated haplotype frequency
The MTHFR c.677C>T and c. 1298A>C variants are in linkage disequil ibrium (r2>0 .8)
based on the data from the HapMap project (CHB population) by using Haploview
software version 4.1. To further validate the results from the genotype analysis, the
haplotype between these two variants were permuted, as shown in table 5.2. The
haplotype analyses showed that the 677T- 1298A haplotype was assoc iated with a
marginal 1.138-fold increased risk for ischemic stroke (95%C I: 1.003 to 1.292, P =
0.045) .
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Tabl e 5.1 Genotype distributions of MTHFR c.677C>T and c.l298 A>C variants in
ischemic stroke patient s and contro l subjects
Genotype Stroke NC OR (95%CI) P-value
(n=1429) (n=1171)
677C>T
CC 174 207
CT 663 535 1.474 (1.170 -1.858) 0.001
rr 592 429 1.642 (1.296 - 2.080) < 0.001
CTm 1255 964 1.549 (1.245-1.927) < 0.001
Allele Frequency .
C 35.4% 40.5%
T 64.6% 59.5% 1.245 (1.112-1.393) <0.001
1298A>C
AA 1129 880
AC 277 269 0.803 (0.664 - 0.970) 0.023
CC 23 22 0.815 (0.451 - 1.472) 0.497
AC/CC 300 291 0.840 (0.669 - 0.966) 0.020
Alle le Frequency.
A 88.7% 86.6%
C 11.3% 13.4% 0.826(0.700- 0.975) 0.024
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Table 5.2 Distribution of haplotype frequencies for MTHFR c.677C>T and
c.1298A>C variants in ischemic stroke and contro l subjects
Haplotype Stroke NC OR (95%CI) P-value
Frequencies (2n=2,858) (2n=2,342)
MTFHR c.677-
c.1298
C-A 737 653
C-C 340 297 1.014 0.882
(0.841- 1.224)
T-A 1769 1377 1.138 0.045
(1.003- 1.292)
T-C 11 16 0.609 (J.2(J(J
(0.281 - 1.322)
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Discussion
In the present study, two common variants, AITHFR c.677C>T and c. 1298A>C, were
genotyped in 1,429 ischemic stroke patients and 1,171 controls from Chinese Han
population in Henan province. The results suggest that: I) the i'vITHFR is associated with
ischemi c stroke in the Chinese Han population, and MTHFR c. 677C>T variant is a risk
factor; 2) the MTHFR c. 1298A>C variantis more likely to play the role of a genetic
marker than a causative variant in association with ischemic stroke; and 3) the MTHFR c.
677T- 1298A is a risk haplotype for ischemic stroke in the Chinese Han populati on.
The MTHFR c.677C>T variant is an extensively studied genetic variant in ischemic
stroke. A recent meta-analysis pooled data from six previous meta-analyses and twelve
case-control studies on the associa tion between MTHFR c.677C>T variant and stroke.
Two of the case-control studies and four of the meta-analyses associated the AfTHFR
c.677T allele with stroke, while the other ten case-control studies and four meta-analyses
failed to validate any associa tion (Bersano et al. 2009) . These inconsistent results may
result from stroke heterogeneity, population admixture and sample bias.
The T allele frequency of MTHFR c.677C>T variant varies among differ ent ethnic
popul ations. According to the HapMap database, the T allele varies from 0.10 in the YRI
(Yoruba in Ibadan) population, 0.24 in the CEU (Caucasian of European descent)
population to 0.48 in the CHB (Chinese Han Beijing) population. The T allele frequency
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also showed differences within the same ethnic population. In Caucasians, the T allele
frequency was reported as 0.33 in Portuguese (Castro et al. 2003), 0042 in Spanish
(Guillen et al. 200 I), and 0044 in Italian (Botto et al. 2000) populations. In the Asian
populations, the T allele frequency was shown to be 0040in Japanese (Kohara et aI2 003),
and 0044in Korean (Kim et al. 2007) and Chinese Han populations (Li et al. 2003) . The T
allele of the MT HFR c.677C>T variant in our study presented a much higher frequency
compared with that in a previous reported Chinese study (0.60 vs.OA4) (Li et al. 2003), of
which the studied subjec ts were collected from several provinces across China. A recent
study also reported significan t ethnic and regional variations concerning the frequency of
MTHFR c.677C>T variant in Chinese (P<O.OI) (Mao et al. 2008). In the publi shed
studies , which showed an assoc iation between the MTHFR c. 677C>T variant and
ischemic stroke, the T allele usually was a minor allele. Interestingly in the present study,
the T allele, as the major allele, was also associa ted with increased risk for ischemic
stroke . This indicates that the MT HFR c.677C>T is a risk variant for stroke, but its effect
may be modified by genetic or environmental effects which vary among different ethnic
populations..
The MTHFR c.1298A>C variant can reduce MTHFR enzyme activity in in vivo (van der
Put et al. 1998, Weisberg et al. 1998) and in vitro (Weis berg et al. 200 1) experiments,
although to a lesser extent than the MTHFR c.677C>T variant. However, the impact of
the MTHF R c.1298A>C variant on plasma homocysteine levels remain unclear. Previous
studies reported that this variant either did not affect the homocysteine levels, or was
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assoc iated with elevated or even reduced homocysteine levels (van der Put et al. 1998,
Friedma n et al. 1999, Lievers et al. 2001, Castro et al. 2003) . Our result sugges ts that the
heterozygous AC genotype associates with lower risk for ischemic stroke, which
contradicts previous studies (Sazci et al 2006, Kim et al 2010). A Korean study indicated
that MTHFR 1298AC (OR: 1.734, 95%C I: 1.13 to 2.66) and AC/CC genotypes (OR;
1.825, 95%C I: 1.20 to 2.78) were assoc iated with moderately increased risk for silent
brain infarc tion in the Korean population (Kim et al. 20 I0). Another study indicated that
the homozygous CC genotype was strongly assoc iated with ischemic stroke in a Turkish
population based on genotyping of 92 cases and 259 controls (OR: 2.950, 95%C I: 1.504
to 5.786, P=O.OO I) (Sazc i et al. 2006). Combining our findings with previous studies, we
consider the MTHFR c.1298A>C variant to be a marker in linkage disequilibrium with a
causative variant rather than a functional variant responsible for ischemic stroke. Further
studies are needed to elucidate the relationship between the MTHFR c.1298A>C variant
and homocysteine metabolism.
The MTHFR c.677C>T and c.1298A>C variants are known to occur in linkage
disequ ilibrium. The haplotype of 677T-1298A, in the present study, was present at
significantly increased prevalence in ischemic stroke patients, and it, therefore, could be
regarded as a risk haplotype for ischemic stroke in the Chinese Han population.
Conclusion
71
Our study demon strated that the lvfTHFR is associated with ischemic stroke in the
Chinese Han population . The l'vfTflFR c. 677C>T variant is a risk factor in this
assoc iation. The MTHFR c. 1298A>C variant is a genetic marker rather than a causative
variant in ischemic stroke. Target sequencing the l'vfTHFR locus with next-generation
technology may help identify the causative variants.
Conflicts of interest
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Chapter 6
Conclusion
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6.1 Combined Ana lysis on Associa tion of MTHFR and 9p21 Variants with Ischem ic
Stroke
A total of 1,429 patients and 1,166 control subjec ts were successfully genotyped for all
six variants examined in the two studies described in chapter 4 and 5. To assess if any
increased risk occurs for coexis tence of risk alleles in 9p21 locus and MTHFR gene. we
selected two variants showed assoc iation with ischemic stroke in chapter 4 and 5,
rs2308207 from 9p2 l locus and MTHFR c.677C>T (rs I801133), respecti vely. We
performed the '"I: analysis and the results were shown in Table 6. 1. With the presence of
both risk allele carrie rs from the two variants, the ORs exceed 2.0, which are greater than
ORs of the two risk alleles, respectively. The ORs for the combined risk genotypes are in
compliance with an additive model when considering their co-effec t on ischemic stroke in
the Chinese Han population. This suggests that coexis tence of both risk genotypes for
these two variants increased risk for ischemic stroke.
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Table 6.1 Distribution of combin ed genotype frequency of rs2383207 and MTHFR
c.677C>T (rs I80 1133) in stroke patients and contro l subjects
Combined Stroke NC OR (95%CI) P-va lue
genotypes (n=1429) (n=1166)
Rs238320 7/
rs1801133
AA/CC 13 24
AA/CT 78 70 2.057 0.056
(0.974 - 4.347)
AAiTT 63 73 1.593 0.224
(0.749 -3.388)
AG/CC 79 95 1.535 0.253
(0.734 -3.211)
AG/CT 278 240 2.138 0.029
(1.065 -4.292)
AG/TT 285 181 2.907 0.002
(1.443-5.855)
GG/CC 82 86 1.760 0.13 I
(0.840 - 3.688)
GG/CT 307 225 2.5 19 0.007
(1.255-5.055)
GG/TT 244 172 2.619 0.006
(1.297 -5.288)
AG+GG/CT+TT 1114(79.8%) 818(70.1%) 1.505 <0.00 1
(1.260 - 1.796)
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6.2 Conclusion
Stroke is a complex disease with multiple risk factors. Animal, familial and twin studies
indicate genetic involvement in stroke predisposition. However, the causative var iants
remain undetermined. Our study confirms the genetic assoc iation of variants within the
MrHFR and the chromosome 9p21 locus with ischemic stroke in the Chinese Han
population. With our results, we conclude:
I . The chromosome 9p21 locus is assoc iated with ischemic stroke in the Chinese
Han population at SNP and Haplotype levels. Our result reduces the candidate
region to 28 kb in the Chinese Han population;
2. The MTHFR is associated with ischemic stroke in the Chinese Han
population: a) The MrHFR c. 677T variant is a risk allele, and its effect could
be modified by genetic or environmental factor(s) which vary among different
ethnic population; b) The MrHFR c. 1298A>C variantis more likely to play
the role of a genetic marker than causative variant in association with ischemic
stroke; c) The MrHFR c. 677T- 1298A is a risk haplotype for ischemic stroke
in the Chinese Han population;
3 . The presence of risk alleles from both the 9p2 l candidate locus and MrHFR
(MrHFR c. 677C>T) confer an additive effect for increased risk of ischemic
stroke in the Chinese Han populatio
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